A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol Dependence

NCT02382276 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

405

Enrollment

INDUSTRY

Sponsor class

Conditions

Alcohol Dependence

Interventions

DRUG: Nalmefene hydrochloride

Sponsor

Otsuka Pharmaceutical Co., Ltd.

Collaborators

[object Object]